MARKET

KMDA

KMDA

Kamada Ltd
NASDAQ
8.47
+0.13
+1.56%
Closed 16:00 04/01 EDT
OPEN
8.36
PREV CLOSE
8.34
HIGH
8.57
LOW
8.36
VOLUME
46.89K
TURNOVER
--
52 WEEK HIGH
9.08
52 WEEK LOW
5.38
MARKET CAP
488.60M
P/E (TTM)
24.47
1D
5D
1M
3M
1Y
5Y
1D
Kamada updates on withholding tax procedures for cash dividend
TipRanks · 1d ago
Kamada Details Israeli Withholding Terms for April 7 Cash Dividend
TipRanks · 1d ago
Kamada Secures Israeli Tax Ruling On $0.25 Dividend, Allowing Reduced Withholding For Nasdaq Treaty Shareholders
Benzinga · 1d ago
Kamada: From Buy To Hold After 22.4% Surge (Rating Downgrade)
Seeking Alpha · 2d ago
Weekly Report: what happened at KMDA last week (0323-0327)?
Weekly Report · 2d ago
Kamada’s plasma center gets FDA nod, targets EMA approval next
Seeking Alpha · 6d ago
Kamada Wins FDA Nod for High-Capacity San Antonio Plasma Center
TipRanks · 6d ago
Kamada announces FDA approval for plasma collection center in San Antonio
TipRanks · 6d ago
More
About KMDA
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Webull offers Kamada Ltd stock information, including NASDAQ: KMDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KMDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KMDA stock methods without spending real money on the virtual paper trading platform.